Q&A: ‘I’m going overseas tomorrow . . . can you witness...

While pharmacists are now (very) familiar with rapid antigen tests (RATs) for COVID-19 testing, the practice of observed RATs for the purpose of international...

PSA’s projects make a bigger impact than ever before

The PSA released its 2025 Strategic Projects Impact Report last week, showcasing its leadership in advancing pharmacist practice.

Treating hypertension – a new approach

Hypertension is the leading cause of cardiovascular disease, affecting 1.13 billion people worldwide, including six million adult Australians. Research has indicated that a new pharmacological...

New opioid patient resource

The balance between adequate pain relief and safety with opioids is now more achievable with the release of a handy new resource for patients...

Q&A: Shadow Federal Health Minister Catherine King

As a supporter of pharmacists, Catherine King MP is a firm believer in having a ‘broader’ role for pharmacists in Australia’s health system. During her...

‘Devastating’ volume of clinical waste generates concern

As environmental threats become increasingly pressing, healthcare professionals are calling for changes in the way clinical waste is managed in medical settings. In a recent...